Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Seoul National University Hospital
Seúl, Corea del SurPublicacións en colaboración con investigadores/as de Seoul National University Hospital (4)
2023
-
Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion–positive non–small cell lung cancer
Expert Review of Anticancer Therapy, Vol. 23, Núm. 1, pp. 95-106
2021
2020
2018
-
Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer
New England Journal of Medicine, Vol. 379, Núm. 21, pp. 2027-2039